China’s GDP has grown 30x from 1990 to 2017, and the annual per capita income of urban households has increased 22x within the past 27 years. Chinese consumers have a lot more disposable income to spend and their needs and purchasing behaviors have evolved. On the other hand, China’s population structure has changed with the aging population ratio growing rapidly. The population of 60-year old and above reached 220 million in 2015, counted as 16.1% of the total population. This has created tremendous opportunities in healthcare products and services that can slow down the aging process, reduce the health impact from aging, maintain and improve health condition, and keep a good quality of life. The 505 Group is a Chinese enterprise has focuses on this segment since 1988 and has built a well-known consumer brand in China. Let’s hear from Lily Dong who is in charge of the overseas market to share her observations of the demand and trend in China’s healthcare product market
About the Guest:
Ms. Lily Dong is the Director of the 505 Group in charging of the overseas markets and product development. She has been with this healthcare product company in 1988 since its founding in Xianyang, Shaanxi, China, and has helped to build this company from zero to a well-known enterprise with global sales. In her 30 years in the healthcare industry in China, Lily has deep insights about the market trends, customers’ needs and sales/marketing operations.
PTCG consultants are leaders, business consultants, corporate coaches, speakers, and trainers with years experience in the technology industry, both US and China.